Real-world experience of autologous stem cell transplant after low dose nivolumab and bendamustine in relapsed/ refractory Hodgkin lymphoma: A case series
Real-world experience of autologous stem cell transplant after low dose nivolumab and bendamustine in relapsed/ refractory Hodgkin lymphoma: A case series. // Pediatric Hematology Oncology Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2468124526000641?dgcid=rss_sd_all
Real-world experience of autologous stem cell transplant after low dose nivolumab and bendamustine in relapsed/ refractory Hodgkin lymphoma: A case series. Pediatric Hematology Oncology Journal. https://www.sciencedirect.com/science/article/pii/S2468124526000641?dgcid=rss_sd_all
“Real-world experience of autologous stem cell transplant after low dose nivolumab and bendamustine in relapsed/ refractory Hodgkin lymphoma: A case series.” Pediatric Hematology Oncology Journal.
@article{article61816,
title = {Real-world experience of autologous stem cell transplant after low dose nivolumab and bendamustine in relapsed/ refractory Hodgkin lymphoma: A case series},
journal = {Pediatric Hematology Oncology Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2468124526000641?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...